{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T09:00:35Z","timestamp":1697101235818},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,9,26]],"date-time":"2007-09-26T00:00:00Z","timestamp":1190764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2007,11,23]]},"DOI":"10.1007\/s11255-007-9276-9","type":"journal-article","created":{"date-parts":[[2007,9,25]],"date-time":"2007-09-25T09:08:41Z","timestamp":1190711321000},"page":"1209-1216","source":"Crossref","is-referenced-by-count":26,"title":["Bone health and vascular calcification relationships in chronic kidney disease"],"prefix":"10.1007","volume":"39","author":[{"given":"Goce B.","family":"Spasovski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,26]]},"reference":[{"key":"9276_CR1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"9276_CR2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/978-94-009-1087-4_44","volume-title":"Replacement of renal function by dialysis","author":"F. Llach","year":"1989","unstructured":"Llach F, Coburn JW (1989) Renal osteodystrophy and maintenance dialysis. In: Maher JF (ed) Replacement of renal function by dialysis, Kluwer, Dordrecht, pp\u00a0911\u2013952"},{"key":"9276_CR3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/ndt\/gfg116","volume":"18","author":"G Spasovski","year":"2003","unstructured":"Spasovski G, Bervoets A, Behets G et al (2003) Spectrum of renal bone disease in end-stage renal failure patients not in dialysis yet. Nephrol Dial Transplant 18:1159\u20131166","journal-title":"Nephrol Dial Transplant"},{"key":"9276_CR4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/039139880402701103","volume":"27","author":"GB Spasovski","year":"2004","unstructured":"Spasovski GB (2004) Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy. Int J Artif Organs 27:918\u2013923","journal-title":"Int J Artif Organs"},{"key":"9276_CR5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.1988.96","volume":"33","author":"IB Salusky","year":"1988","unstructured":"Salusky IB, Coburn JW, Brill J et al (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975\u2013982","journal-title":"Kidney Int"},{"key":"9276_CR6","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","volume":"97","author":"E Slatopolsky","year":"1996","unstructured":"Slatopolsky E, Finch J, Denda M et al (1996) Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534","journal-title":"J Clin Invest"},{"key":"9276_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM199102213240804","volume":"324","author":"IB Salusky","year":"1991","unstructured":"Salusky IB, Foley J, Nelson P, Goodman WG (1991) Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N Engl J Med 324:327","journal-title":"N Engl J Med"},{"key":"9276_CR8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.1988.258","volume":"34","author":"LD Quarles","year":"1988","unstructured":"Quarles LD, Davidai GA, Schwab SJ et al (1988) Oral calcitriol and calcium: efficient therapy for uremic hyperparathyroidism. Kidney Int 34:840","journal-title":"Kidney Int"},{"key":"9276_CR9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0272-6386(85)80089-5","volume":"6","author":"WG Goodman","year":"1985","unstructured":"Goodman WG (1985) Bone disease and aluminum: pathogenic considerations. Am J Kidney Dis 6:330\u2013335","journal-title":"Am J Kidney Dis"},{"key":"9276_CR10","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","volume":"47","author":"A Torres","year":"1995","unstructured":"Torres A, Lorenzo V, Hernandez D (1995) Bone disease in predialysis, hemodialysis and CAPD patients: evidence for a better response to PTH. Kidney Int 47:1434\u20131442","journal-title":"Kidney Int"},{"key":"9276_CR11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","volume":"43","author":"DJ Sherrard","year":"1993","unstructured":"Sherrard DJ, Hercz G, Pei Y et al (1993) The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder. Kidney Int 43:436\u2013442","journal-title":"Kidney Int"},{"key":"9276_CR12","first-page":"616A","volume":"10","author":"T Akizawa","year":"1999","unstructured":"Akizawa T, Kinugasa E, Kurihara S (1999) Parathyroid hormone deficiency is an indicator of poor nutritional state and prognosis in dialysis patients. J Am Soc Nephrol 10:616A","journal-title":"J Am Soc Nephrol"},{"key":"9276_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jbmr.5650100121","volume":"10","author":"Y Pei","year":"1995","unstructured":"Pei Y, Hercz G, Greenwood C (1995) Risk factors for renal osteodystrophy. A multivariant analysis. J Bone Miner Res 10:149\u2013156","journal-title":"J Bone Miner Res"},{"key":"9276_CR14","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/ndt\/12.10.2144","volume":"12","author":"MM Couttenye","year":"1997","unstructured":"Couttenye MM, D\u2019Haese PC, Deng JT et al (1997) High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population. Nephrol Dial Transplant 12:2144\u20132150","journal-title":"Nephrol Dial Transplant"},{"key":"9276_CR15","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","volume":"20","author":"Y Iwasaki-Ishizuka","year":"2005","unstructured":"Iwasaki-Ishizuka Y, Yamato H, Nii-Kono T, Kurokawa K, Fukagawa M (2005) Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid. Nephrol Dial Transplant 20:1904\u20131911","journal-title":"Nephrol Dial Transplant"},{"key":"9276_CR16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1523-1755.2004.00472.x","volume":"65","author":"S Disthabanchong","year":"2004","unstructured":"Disthabanchong S, Hassan H, Mcconkey CL, Martin KJ, Gonzalez EA (2004) Regulation of PTH1 receptor expression by uremic ultrafiltrate in UMR 106\u201301 osteoblast-like cells. Kidney Int 65:897\u2013903","journal-title":"Kidney Int"},{"key":"9276_CR17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ki.1993.350","volume":"44","author":"AJ Hutchison","year":"1993","unstructured":"Hutchison AJ, Whitehouse RW, Boulton HF et al (1993) Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 44:1071\u20131077","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"9276_CR18","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1177\/089686089901902S65","volume":"19","author":"SK Shin","year":"1999","unstructured":"Shin SK, Kim DH, Kim HS et al (1999) Renal osteodystrophy in pre-dialysis patients: ethnic difference? Perit Dial Int 19(Suppl 2):S402\u2013S407","journal-title":"Perit Dial Int"},{"issue":"Suppl 85","key":"9276_CR19","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1046\/j.1523-1755.63.s85.18.x","volume":"63","author":"PC D\u2019Haese","year":"2003","unstructured":"D\u2019Haese PC, Spasovski G, Sikole A et al (2003) Multi-centre study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int 63(Suppl 85): S73\u2013S78","journal-title":"Kidney Int"},{"key":"9276_CR20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","volume":"36","author":"M Coco","year":"2000","unstructured":"Coco M, Rush H (2000) Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115\u20131121","journal-title":"Am J Kidney Dis"},{"key":"9276_CR21","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin SJ, Kuizon BD (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478\u20131483","journal-title":"N Engl J Med"},{"key":"9276_CR22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0272-6386(96)90363-7","volume":"27","author":"J Braun","year":"1996","unstructured":"Braun J, Oldendorf M, Moshage W et al (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394\u2013401","journal-title":"Am J Kidney Dis"},{"key":"9276_CR23","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1523-1755.2004.00894.x","volume":"66","author":"G Eknoyan","year":"2004","unstructured":"Eknoyan G, Lameire N, Barsoum R et al (2004) The burden of kidney disease: improving global outcomes. Kidney Int 66:1310\u20131314","journal-title":"Kidney Int"},{"key":"9276_CR24","first-page":"77","volume-title":"Clinical guide to the basics of bone and mineral metabolism in CKD","author":"GA Block","year":"2006","unstructured":"Block GA, Cunningham J (2006) Morbidity and mortality associated with abnormalities in bone and mineral metabolism in CKD. In: Olgaard K (ed) Clinical guide to the basics of bone and mineral metabolism in CKD. National Kidney Foundation, New York, pp\u00a077\u201392"},{"key":"9276_CR25","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/ki.1997.233","volume":"51","author":"G London","year":"1997","unstructured":"London G, Drueke T (1997) Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 51:1678\u20131695","journal-title":"Kidney Int"},{"key":"9276_CR26","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ et al (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112\u2013S119","journal-title":"Am J Kidney Dis"},{"key":"9276_CR27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","volume":"38","author":"J Blacher","year":"2001","unstructured":"Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938\u2013942","journal-title":"Hypertension"},{"issue":"Suppl","key":"9276_CR28","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1111\/j.1523-1755.2005.09507.x","volume":"95","author":"WY Qunibi","year":"2005","unstructured":"Qunibi WY (2005) Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with end-stage renal disease (ESRD). Kidney Int 95(Suppl):S43\u2013S50","journal-title":"Kidney Int"},{"key":"9276_CR29","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI117246","volume":"93","author":"CM Shanahan","year":"1994","unstructured":"Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL (1994) High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393\u20132402","journal-title":"J Clin Invest"},{"key":"9276_CR30","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.100.21.2168","volume":"100","author":"CM Shanahan","year":"1999","unstructured":"Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME (1999) Medial localization of mineralization\u2013regulating proteins in association with Monckeberg\u2019s sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100:2168\u20132176","journal-title":"Circulation"},{"key":"9276_CR31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.mnh.0000172723.52499.38","volume":"14","author":"CM Shanahan","year":"2005","unstructured":"Shanahan CM (2005) Vascular calcification. Curr Opin Nephrol Hypertens 14:361\u2013367","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"9276_CR32","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1053\/ajkd.2001.29283","volume":"38","author":"KJ Martin","year":"2001","unstructured":"Martin KJ, Gonzalez EA (2001) Strategies to minimize bone disease in renal failure. Am J Kidney Dis 38:1430\u20131436","journal-title":"Am J Kidney Dis"},{"key":"9276_CR33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","volume":"15","author":"LA Stevens","year":"2004","unstructured":"Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A (2004) Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 15:770\u2013779","journal-title":"J Am Soc Nephrol"},{"key":"9276_CR34","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.ki.5002241","volume":"71","author":"KR Neves","year":"2007","unstructured":"Neves KR, Graciolli FG, dos Reis LM et al (2007) Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int 71:1262\u20131270","journal-title":"Kidney Int"},{"key":"9276_CR35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.ATV.21.5.817","volume":"21","author":"PA Price","year":"2001","unstructured":"Price PA, Faus SA, Williamson MK (2001) Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21:817\u2013824","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9276_CR36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0272-6386(04)00937-0","volume":"44","author":"K Nitta","year":"2004","unstructured":"Nitta K, Akiba T, Suzuki K, Uchida K, Watanabe R et al (2004) Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 44:680\u2013688","journal-title":"Am J Kidney Dis"},{"key":"9276_CR37","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco AL et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516\u20131525","journal-title":"N Engl J Med"},{"key":"9276_CR38","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1681\/ASN.V1291978","volume":"12","author":"IB Salusky","year":"2001","unstructured":"Salusky IB, Goodman WG (2001) Adynamic renal osteodystrophy: is there a problem? J Am Soc Nephrol 12:1978\u20131985","journal-title":"J Am Soc Nephrol"},{"key":"9276_CR39","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","volume":"46","author":"P Kurz","year":"1994","unstructured":"Kurz P, Monier-Faugere MC, Bognar B et al (1994) Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855\u2013861","journal-title":"Kidney Int"},{"key":"9276_CR40","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","volume":"15","author":"GM London","year":"2004","unstructured":"London GM, Marty C, Marchais SJ et al (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943\u20131951","journal-title":"J Am Soc Nephrol"},{"key":"9276_CR41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00041552-200109000-00003","volume":"10","author":"NW Levin","year":"2001","unstructured":"Levin NW, Hoenich NA (2001) Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypert 10:563\u2013568","journal-title":"Curr Opin Nephrol Hypert"},{"issue":"Suppl 3","key":"9276_CR42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","volume":"44","author":"EW Young","year":"2004","unstructured":"Young EW, Akiba T, Albert JM et al (2004) Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44(Suppl 3):34\u201338","journal-title":"Am J Kidney Dis"},{"key":"9276_CR43","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208\u20132218","journal-title":"J Am Soc Nephrol"},{"key":"9276_CR44","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","volume":"87","author":"S Jono","year":"2000","unstructured":"Jono S, McKee MD, Murry CE et al (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10\u2013E17","journal-title":"Circ Res"},{"key":"9276_CR45","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","volume":"15","author":"JL Reynolds","year":"2004","unstructured":"Reynolds JL, Joannides AJ, Skepper JN et al (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extra-cellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857\u20132867","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"9276_CR46","first-page":"51","volume":"36","author":"SM Moe","year":"2006","unstructured":"Moe SM (2006) Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Eur J Clin Invest 36(Suppl 2):51\u201362","journal-title":"Eur J Clin Invest"},{"key":"9276_CR47","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607\u2013617","journal-title":"Am J Kidney Dis"},{"key":"9276_CR48","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","volume":"67","author":"EW Young","year":"2005","unstructured":"Young EW, Albert JM, Satayathum S et al (2005) Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 67:1179\u20131187","journal-title":"Kidney Int"},{"issue":"Suppl. 71","key":"9276_CR49","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1046\/j.1523-1755.1999.07163.x","volume":"56","author":"K Kimura","year":"1999","unstructured":"Kimura K, Saika Y, Otani H, Fujii R, Mune M, Yukawa S (1999) Factors associated with calcification of the abdominal aorta in hemodialysis patients. Kidney Int 56(Suppl. 71):S238\u2013S241","journal-title":"Kidney Int"},{"key":"9276_CR50","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","volume":"97","author":"E Slatopolsky","year":"1996","unstructured":"Slatopolsky E, Finch J, Denda M et al (1996) Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in\u00a0vitro. J Clin Invest 97:2534\u20132540","journal-title":"J Clin Invest"},{"key":"9276_CR51","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1523-1755.1998.00875.x","volume":"53","author":"I Mucsi","year":"1998","unstructured":"Mucsi I, Hercz G, Uldall R et al (1998) Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53:1399\u20131404","journal-title":"Kidney Int"},{"key":"9276_CR52","unstructured":"De Broe ME, Coburn JW (1990) Aluminum and renal failure. In: Developments in Nephrology,vol 26. Kluwer Dordrecht, pp\u00a099\u2013375"},{"key":"9276_CR53","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","volume":"15","author":"AP Guerin","year":"2000","unstructured":"Guerin AP, London GM, Marchais SJ, Metivier F (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014\u20131021","journal-title":"Nephrol Dial Transplant"},{"key":"9276_CR54","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731\u20131740","journal-title":"Nephrol Dial Transplant"},{"key":"9276_CR55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0272-6386(97)90352-8","volume":"29","author":"CH Hsu","year":"1997","unstructured":"Hsu CH (1997) Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 29:641\u2013649","journal-title":"Am J Kidney Dis"},{"key":"9276_CR56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"GM Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245\u2013252","journal-title":"Kidney Int"},{"key":"9276_CR57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1681\/ASN.2006050490","volume":"18","author":"M Suresh","year":"2007","unstructured":"Suresh M, Richard JL, Frank S et al (2007) Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol 18:122\u2013130","journal-title":"J Am Soc Nephrol"},{"key":"9276_CR58","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/JBMR.041221","volume":"20","author":"P Raggi","year":"2005","unstructured":"Raggi P, James G, Burke SK et al (2005) Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. J Bone Miner Res 20:764\u2013772","journal-title":"J Bone Miner Res"},{"key":"9276_CR59","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/ndt\/gfl146","volume":"532","author":"GB Spasovski","year":"2006","unstructured":"Spasovski GB, Gelev S, Sikole A, Masin-Spasovska J et al (2006) Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1-year treatment with lanthanum carbonate and after two years of follow up. Nephrol Dial Transplant 532:2217\u20132224","journal-title":"Nephrol Dial Transplant"},{"key":"9276_CR60","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","volume":"20","author":"R Vanholder","year":"2005","unstructured":"Vanholder R, Massy Z, Argiles A, Spasovski G et al (2005) Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20:1048\u20131056","journal-title":"Nephrol Dial Transplant"},{"key":"9276_CR61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.ki.5000417","volume":"70","author":"C Zoccali","year":"2006","unstructured":"Zoccali C (2006) Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 70:26\u201333","journal-title":"Kidney Int"},{"key":"9276_CR62","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1524-4733.2005.00049.x","volume":"8","author":"KF Huybrechts","year":"2005","unstructured":"Huybrechts KF, Caro JJ, Wilson DA, O\u2019Brien JA (2005) Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysis. Value Health 8:549\u2013561","journal-title":"Value Health"},{"issue":"Suppl 2","key":"9276_CR63","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1681\/ASN.2005060662","volume":"16","author":"CR Nolan","year":"2005","unstructured":"Nolan CR (2005) Strategies for improving long-term survival in patients with ESRD. J Am Soc Nephrol 16(Suppl 2):S120\u2013S127","journal-title":"J Am Soc Nephrol"},{"key":"9276_CR64","first-page":"397","volume":"13","author":"MS Joy","year":"2007","unstructured":"Joy MS, Karagiannis PC, Peyerl FW (2007) Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm 13:397\u2013411","journal-title":"J Manag Care Pharm"},{"key":"9276_CR65","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5001666","volume":"70","author":"A Haris","year":"2006","unstructured":"Haris A, Sherrard DJ, Hercz G (2006) Reversal of adynamic bone disease by lowering of dialysate calcium. Kidney Int 70:931\u2013937","journal-title":"Kidney Int"},{"key":"9276_CR66","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bone.2007.06.014","volume":"41","author":"G Spasovski","year":"2007","unstructured":"Spasovski G, Gelev S, Masin-Spasovska J et al (2007) Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium. Bone 41:698\u2013703","journal-title":"Bone"},{"key":"9276_CR67","doi-asserted-by":"crossref","unstructured":"K\/DOQI, NKF (2003) Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1\u2013S201","DOI":"10.1016\/S0272-6386(03)00905-3"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-007-9276-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-007-9276-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-007-9276-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T06:36:51Z","timestamp":1629787011000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-007-9276-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,26]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,11,23]]}},"alternative-id":["9276"],"URL":"https:\/\/doi.org\/10.1007\/s11255-007-9276-9","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,26]]}}}